FDAnews Drug Daily Bulletin

HHS’ proposed privacy rule that loosens restrictions on clinical trials strikes an appropriate balance between a researcher’s need for access to health information and protection of a subject’s privacy, according to the Association of Clinical Research Organizations (ACRO). The proposed rule would allow sponsors to use a trial subject’s informed consent for multiple uses, or compound authorizations, so long as the uses are related to the same trial.
Clinical Trials Advisor